Loading...

206 posters, 13 topics, 5 sessions, 713 authors, 293 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

AAPS 104th Annual Meeting

May 2-5, 2026 | Lihue, HI

AAPS 104th Annual Meeting banner

D67

Patient Reported Outcome Measures Following Breast Reconstruction: A Systematic Review And Meta-analysis Utilizing The Breast-Q

Part of Topic

Aesthetic Breast/Body Contouring

Background

Patient-reported outcome measures (PROMs) play a crucial role in evaluating the success of breast reconstruction. The BREAST-Q provides a standardized measure of satisfaction and quality of life; however, comparative outcomes between autologous– and implant-based breast reconstruction (ABBR and IBBR) remain incompletely defined. This meta-analysis compared PROMs between ABBR and IBBR using the BREAST-Q.

Methods

A systematic search of PubMed, Embase, Scopus, Web of Science, and CENTRAL was conducted from database inception through May 2025. Studies comparing PROMs using the BREAST-Q in patients undergoing ABBR vs. IBBR were included. Pooled analyses were performed using a random-effects model, risk of bias was assessed with ROBINS-I and RoB 2.0, and certainty of evidence was assessed with GRADE.

Results

Thirty-nine studies comprising 22,798 patients (6,899 ABBR; 15,899 IBBR) were included. ABBR was associated with significantly higher satisfaction with breasts (SMD, 0.49; 95% CI [0.36–0.61]; p < 0.001), psychosocial well-being (SMD, 0.27; 95% CI [0.18–0.35]; p < 0.001), satisfaction with outcome (SMD, 0.53; 95% CI [0.36–0.70]; p < 0.001), and sexual well-being (0.27; 95% CI [0.17–0.37]; p < 0.001). Physical well-being differences were modest (SMD, 0.16; 95% CI [0.06–0.25]; p = 0.001). ABBR was associated with higher rates of minor complications (OR 2.44) but lower reoperation rates (OR 0.38). 

Conclusion

Autologous reconstruction was associated with higher patient-reported outcome measures and clinically meaningful advantages in the aesthetic and overall outcome domains. These findings support individualized reconstructive decision-making that balances early morbidity against long-term quality-of-life benefit.

aaps2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.